Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 41, 2011 - Issue 7
Submit an article Journal homepage
124
Views
2
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetics and Metabolism

Pharmacokinetics of antofloxacin hydrochloride in healthy male subjects after multiple intravenous dose administration

J. WangInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing, China
,
Y. XiaoInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing, ChinaCorrespondence[email protected]
,
Y. LuInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing, China
,
Z. KangInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing, China
,
M. ZhangInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing, China
,
Y. LiuInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing, China
,
J. LiangInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing, China
,
M. ZhangInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing, China
&
T. LiInstitute of Clinical Pharmacology, First Hospital, Peking University, Beijing, China
 show all
Pages 561-566 | Received 12 Dec 2010, Accepted 21 Feb 2011, Published online: 29 Mar 2011

References

  • Kaitin KI. (1998). Global drug development and international harmonization: the emergence of China as a world pharmaceutical player. Drug Inform J 32:1187S–1191S.
  • Li CJ, Chen DY, Chen KX. (2004). Current status of drug discovery and development in China. Chin Bull Life Sci 16:324–329.
  • Liang Y, Liu L, Lu S, Xie L, Kang A, Xie T, Xie Y, Sheng L, Liu X, Wang GJ. (2009). Application of a hybrid ion trap/time-of-flight mass spectrometer in metabolite characterization studies: structural identification of the metabolism profile of antofloxacin in rats rapidly using MSn information and accurate mass measurements. J Pharm Biomed Anal 50:1022–1025.
  • Lin HY, Shen HL. (2006). Antibiotics clinical usage in general hospital. Chin J Nosocomial 16:681–683.
  • Lode H, Borner K, Koeppe P. (1998). Pharmacodynamics of fluoroquinolones. Clin Infect Dis 27:33–39.
  • Meibohm B, Derendorf H. (2002). Pharmacokinetic/pharmacodynamic studies in drug product development. J Pharm Sci 91:18–31.
  • Schaefer HG, Ahr G, Kuhlmann J. (1995). Pharmacokinetic development of quinolone antibiotics. Int J Clin Pharmacol Ther 33:266–276.
  • Tayab ZR, Hochhaus G, Kaufmann S, Jäger D, Barth J. (2006). Do intensive care patients need an individualized dosing regimen for levofloxacin? Int J Clin Pharmacol Ther 44:262–269.
  • Wang J, Xiao Y, Huang W, Xu N, Bai C, Xiu Q, Mei C, Zheng Q. (2010a). A phase II study of antofloxacin hydrochloride, a novel fluoroquinolone, for the treatment of acute bacterial infections. Chemotherapy 56:378–385.
  • Wang J, Xiao Y, Lu Y, Kang Z, Zhang M, Liu Y, Liang J, Zhang M, Li T. (2010b). Pharmacokinetics of antofloxacin hydrochloride, a novel fluoroquinolone, after single-dose intravenous administration in healthy Chinese male volunteers. Xenobiotica 40:344–349.
  • Xiao XM, Xiao YH. (2008). Pharmacokinetics/pharmacodynamics of antofloxacin hydrochloride in a neutropenic murine thigh model of Staphylococcus aureus infection. Acta Pharmacol Sin 29:1253–1260.
  • Xiao Y, Lu Y, Kang Z, Zhang M, Liu Y, Zhang M, Li T. (2008a). Pharmacokinetics of antofloxacin hydrochloride, a new fluoroquinolone antibiotic, after single oral dose administration in Chinese healthy male volunteers. Biopharm Drug Dispos 29:167–172.
  • Xiao Y, Lu Y, Kang Z, Hou F, Wang S, Li T, Liu Y, Xia Y. (2008b). Tolerability and pharmacokinetics of antofloxacin hydrochloride after multiple oral dose administration in healthy Chinese male volunteers. Int J Clin Pharmacol Ther 46:172–179.
  • Ye H, Wu JM, Yang YS, Chen KX, Ji RY. (2002). Antibacterial activities of the derivatives—YH54 and Yh57 of levofloxacin in vitro. Chin Pharmacol Bull 18:112–113.
  • Zhu Q, Liao J, Xie L, Wang GJ, Liu XD. (2009). Mechanism-based inhibition of CYP1A2 by antofloxacin, an 8-NH2 derivative of levofloxacin in rats. Xenobiotica 39:293–301.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.